Robert McRae - Apr 3, 2023 Form 4 Insider Report for PALISADE BIO, INC. (PALI)

Signature
/s/ Robert McRae
Stock symbol
PALI
Transactions as of
Apr 3, 2023
Transactions value $
-$540
Form type
4
Date filed
4/5/2023, 06:52 PM
Previous filing
Feb 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PALI Common Stock, par value $0.01 Options Exercise $0 +655 +272.92% $0.00 895 Apr 3, 2023 Direct F1
transaction PALI Common Stock, par value $0.01 Tax liability -$540 -270 -30.17% $2.00 625 Apr 3, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PALI Restricted Stock Units Options Exercise -655 -25.02% 1.96K Apr 3, 2023 Common Stock 655 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.
F2 Represents shares withheld by Issuer to satisfy tax withholding requirements on vesting of restricted stock units.
F3 This restricted stock unit was granted on January 3, 2023, and 655 restricted stock units subject to the award vested on April 3, 2023, and approximately 654 restricted stock units are scheduled to vest on each of July 3, 2023, October 3, 2023, and January 3, 2023, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting.